中华肿瘤杂志
中華腫瘤雜誌
중화종류잡지
CHINESE JOURNAL OF ONCOLOGY
2013年
8期
613-617
,共5页
李强%杨仁杰%朱旭%朱林忠%王茂强%段峰
李彊%楊仁傑%硃旭%硃林忠%王茂彊%段峰
리강%양인걸%주욱%주림충%왕무강%단봉
肝肿瘤%肝外侧支动脉%经导管动脉化疗栓塞术%治疗结果%并发症
肝腫瘤%肝外側支動脈%經導管動脈化療栓塞術%治療結果%併髮癥
간종류%간외측지동맥%경도관동맥화료전새술%치료결과%병발증
Liver neoplasms%Extrahepatic collateral arteries%Transcatheter arterial chemoembolization%Treatment outcome%Complications
目的 探讨肝外侧支动脉对肝癌供血的规律及其临床意义.方法 2006年8月至2010年8月间,874例存在肝外侧支动脉供血的肝细胞癌(HCC)患者行经导管动脉化疗栓塞术(TACE) 1356例次,对具体血管途径、例次、栓塞成功率以及并发症类型、发生率进行回顾性分析.结果 右膈下动脉、左膈下动脉、右内乳动脉、左内乳动脉、右肋间动脉、网膜动脉、结肠动脉、胆囊动脉、胃左动脉、胃右动脉以及右肾包膜动脉、右肾上腺下动脉和右肾上腺中动脉的TACE发生率分别为76.3%、2.4%、6.9%、0.4%、2.9%、2.0%、0.8%、2.3%、1.3%、1.1%和3.5%,TACE成功率分别为95.9%、93.8%、100.0%、100.0%、55.0%、77.8%、63.6%、67.7%、76.5%、73.3%和95.8%.5.6%的右膈下动脉供血病灶位于肝脏深部,其余所有肝外侧支动脉供血病灶均累及或者接近肝脏表面.96.0%的患者有TACE治疗史.TACE并发症包括肩胛或后背区疼痛、酸胀、皮肤坏死、胆囊炎、下肺叶盘状肺不张、少量胸腔积液和呃逆等.结论 经肝外侧支动脉行TACE,技术上安全可行.
目的 探討肝外側支動脈對肝癌供血的規律及其臨床意義.方法 2006年8月至2010年8月間,874例存在肝外側支動脈供血的肝細胞癌(HCC)患者行經導管動脈化療栓塞術(TACE) 1356例次,對具體血管途徑、例次、栓塞成功率以及併髮癥類型、髮生率進行迴顧性分析.結果 右膈下動脈、左膈下動脈、右內乳動脈、左內乳動脈、右肋間動脈、網膜動脈、結腸動脈、膽囊動脈、胃左動脈、胃右動脈以及右腎包膜動脈、右腎上腺下動脈和右腎上腺中動脈的TACE髮生率分彆為76.3%、2.4%、6.9%、0.4%、2.9%、2.0%、0.8%、2.3%、1.3%、1.1%和3.5%,TACE成功率分彆為95.9%、93.8%、100.0%、100.0%、55.0%、77.8%、63.6%、67.7%、76.5%、73.3%和95.8%.5.6%的右膈下動脈供血病竈位于肝髒深部,其餘所有肝外側支動脈供血病竈均纍及或者接近肝髒錶麵.96.0%的患者有TACE治療史.TACE併髮癥包括肩胛或後揹區疼痛、痠脹、皮膚壞死、膽囊炎、下肺葉盤狀肺不張、少量胸腔積液和呃逆等.結論 經肝外側支動脈行TACE,技術上安全可行.
목적 탐토간외측지동맥대간암공혈적규률급기림상의의.방법 2006년8월지2010년8월간,874례존재간외측지동맥공혈적간세포암(HCC)환자행경도관동맥화료전새술(TACE) 1356례차,대구체혈관도경、례차、전새성공솔이급병발증류형、발생솔진행회고성분석.결과 우격하동맥、좌격하동맥、우내유동맥、좌내유동맥、우륵간동맥、망막동맥、결장동맥、담낭동맥、위좌동맥、위우동맥이급우신포막동맥、우신상선하동맥화우신상선중동맥적TACE발생솔분별위76.3%、2.4%、6.9%、0.4%、2.9%、2.0%、0.8%、2.3%、1.3%、1.1%화3.5%,TACE성공솔분별위95.9%、93.8%、100.0%、100.0%、55.0%、77.8%、63.6%、67.7%、76.5%、73.3%화95.8%.5.6%적우격하동맥공혈병조위우간장심부,기여소유간외측지동맥공혈병조균루급혹자접근간장표면.96.0%적환자유TACE치료사.TACE병발증포괄견갑혹후배구동통、산창、피부배사、담낭염、하폐협반상폐불장、소량흉강적액화애역등.결론 경간외측지동맥행TACE,기술상안전가행.
Objective To evaluate the incidence of extrahepatic collateral arteries involved in the blood supply to hepatocellular carcinoma (HCC) and to assess the technical success rates and complications of transcatheter arterial chemoembolization (TACE) through the collaterals.Methods 1356 TACE procedures were performed in 874 consecutive patients through extrahepatic collateral pathways to HCC between August 2006 and August 2010 in our department.The extrahepatic collateral pathways to HCC revealed on angiography were retrospectively evaluated.TACE through extrahepatic collaterals using iodized oil and gelatin sponge particles was performed when a catheter was advanced into the feeding branch to avoid nontarget embolization.Results Incidences of collateral source to HCC were 76.3% from the right inferior phrenic artery (RIPA),2.4% from the left inferior phrenic artery (LIPA),6.9% from the right and 0.4%from the left internal mammary arteries (RIMA,LIMA),2.9% from the right intercostal artery (RICA),2.0% from the omental artery,0.8% from the right or middle colic artery,2.3% from the cystic artery,1.3% from the left and 1.1% from the right gastric arteries (LGA,RGA),3.5% from the right renal capsular artery (RRCA),right middle adrenal artery (RMAA) and right inferior adrenal artery (IAA).Technical success rates of TACE were 95.9% in the RIPA,93.8% in the LIPA,100.0% in the RIMA and LIMA,55.0% in the RICA,77.8% in the omental artery,63.6% in the colic artery,67.7% in the cystic artery,76.5% in the LGA,73.3% in the RGA and 95.8% in the RRCA,RMAA,and RIAA.Complications included skin erythema and necrosis after TACE through the RIMA,skin erythema after TACE through the RICA,cholecystitis after TACE through the cystic artery (n =1),and pleural effusion,basal atelectasis and hiccup after TACE through the IPA.Conclusion TACE through extrahepatic collaterals is safe and feasible,and with a high success rate in the treatment of hepatocellular carcinoma.